Robbie Marcus
Stock Analyst at JP Morgan
(1.6)
# 1448
Out of 5,344 analysts
162
Total ratings
52.04%
Success rate
10.29%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
NPCE NeuroPace | Maintains: Overweight | 14 16 | 17.73 | -9.76% | 5 | May 14, 2025 | |
CVRX CVRx | Downgrades: Underweight | 15 7 | 6.66 | 5.11% | 6 | May 9, 2025 | |
ZBH Zimmer Biomet Holdin... | Maintains: Overweight | 128 105 | 92.75 | 13.21% | 6 | May 6, 2025 | |
IART Integra Lifesciences | Maintains: Underweight | 24 12 | 12.31 | -2.52% | 6 | May 6, 2025 | |
INSP Inspire Medical Syst... | Maintains: Overweight | 235 195 | 143.18 | 36.19% | 5 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 70 58 | 55.37 | 4.75% | 7 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | 40 17 | 15.68 | 8.42% | 5 | Apr 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 120 | 95.43 | 25.75% | 1 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 120 110 | 78.89 | 39.43% | 4 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 38 36 | 30.16 | 19.36% | 13 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 420 445 | 376.8 | 18.1% | 7 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 575 675 | 539.54 | 25.11% | 5 | Jan 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Neutral | 12 13 | 6.54 | 98.78% | 3 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 100 110 | 104.56 | 5.2% | 9 | Dec 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 280 330 | 321.32 | 2.7% | 4 | Dec 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 32 | 16.61 | 92.66% | 1 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 30 40 | 32.77 | 22.06% | 5 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 72 78 | 75.03 | 3.96% | 4 | Oct 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 75 85 | 84.56 | 0.52% | 2 | Oct 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 90 | 69.22 | 30.02% | 1 | Sep 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 53 50 | 31.6 | 58.23% | 2 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | n/a | n/a | n/a | 5 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 15 8 | 5.89 | 35.82% | 2 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 19 21 | n/a | n/a | 3 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 284 250 | 268.72 | -6.97% | 9 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 10 16 | 8.27 | 93.47% | 3 | Dec 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 8 7 | 6.54 | 7.03% | 11 | Nov 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 15 17 | 11.29 | 50.58% | 2 | Feb 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 125 118 | 131.45 | -10.23% | 5 | Oct 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | n/a | n/a | n/a | 2 | Aug 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 116 156 | 142.78 | 9.26% | 2 | Jan 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 130 105 | 80.68 | 30.14% | 6 | Dec 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | n/a | n/a | n/a | 2 | Nov 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | 220 | n/a | n/a | 2 | Sep 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | 10 6 | n/a | n/a | 5 | Aug 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 55 40 | 96.2 | -58.42% | 2 | May 5, 2020 |